MOH vs. BNTX
Compare and contrast key facts about Molina Healthcare, Inc. (MOH) and BioNTech SE (BNTX).
Performance
MOH vs. BNTX - Performance Comparison
Loading graphics...
MOH vs. BNTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
MOH Molina Healthcare, Inc. | -21.74% | -40.37% | -19.45% | 9.41% | 3.82% | 49.56% | 56.74% | 20.03% |
BNTX BioNTech SE | -6.07% | -16.45% | 7.97% | -29.74% | -40.40% | 216.24% | 140.61% | 137.92% |
Fundamentals
MOH:
$6.90B
BNTX:
$21.92B
MOH:
$8.92
BNTX:
-$4.68
MOH:
0.16
BNTX:
7.56
MOH:
1.70
BNTX:
1.14
MOH:
$45.43B
BNTX:
$2.86B
MOH:
$3.37B
BNTX:
$2.22B
MOH:
$976.00M
BNTX:
-$635.06M
Returns By Period
In the year-to-date period, MOH achieves a -21.74% return, which is significantly lower than BNTX's -6.07% return.
MOH
- 1D
- 1.89%
- 1M
- -10.89%
- YTD
- -21.74%
- 6M
- -29.55%
- 1Y
- -58.55%
- 3Y*
- -20.22%
- 5Y*
- -10.42%
- 10Y*
- 7.66%
BNTX
- 1D
- 0.61%
- 1M
- -16.80%
- YTD
- -6.07%
- 6M
- -12.51%
- 1Y
- -0.96%
- 3Y*
- -10.46%
- 5Y*
- -4.29%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MOH vs. BNTX — Risk / Return Rank
MOH
BNTX
MOH vs. BNTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Molina Healthcare, Inc. (MOH) and BioNTech SE (BNTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MOH | BNTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.00 | -0.02 | -0.98 |
Sortino ratioReturn per unit of downside risk | -1.36 | 0.33 | -1.70 |
Omega ratioGain probability vs. loss probability | 0.79 | 1.05 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | -0.90 | -0.06 | -0.84 |
Martin ratioReturn relative to average drawdown | -1.28 | -0.12 | -1.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| MOH | BNTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.00 | -0.02 | -0.98 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.27 | -0.08 | -0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.19 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.25 | 0.43 | -0.18 |
Correlation
The correlation between MOH and BNTX is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
MOH vs. BNTX - Dividend Comparison
Neither MOH nor BNTX has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
MOH Molina Healthcare, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BNTX BioNTech SE | 0.00% | 0.00% | 0.00% | 0.00% | 2.43% |
Drawdowns
MOH vs. BNTX - Drawdown Comparison
The maximum MOH drawdown since its inception was -70.76%, smaller than the maximum BNTX drawdown of -82.08%. Use the drawdown chart below to compare losses from any high point for MOH and BNTX.
Loading graphics...
Drawdown Indicators
| MOH | BNTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.76% | -82.08% | +11.32% |
Max Drawdown (1Y)Largest decline over 1 year | -65.28% | -30.40% | -34.88% |
Max Drawdown (5Y)Largest decline over 5 years | -70.76% | -82.08% | +11.32% |
Max Drawdown (10Y)Largest decline over 10 years | -70.76% | — | — |
Current DrawdownCurrent decline from peak | -67.63% | -79.55% | +11.92% |
Average DrawdownAverage peak-to-trough decline | -24.31% | -55.54% | +31.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 46.09% | 15.12% | +30.97% |
Volatility
MOH vs. BNTX - Volatility Comparison
The current volatility for Molina Healthcare, Inc. (MOH) is 12.21%, while BioNTech SE (BNTX) has a volatility of 23.89%. This indicates that MOH experiences smaller price fluctuations and is considered to be less risky than BNTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| MOH | BNTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.21% | 23.89% | -11.68% |
Volatility (6M)Calculated over the trailing 6-month period | 45.88% | 33.34% | +12.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.53% | 50.27% | +8.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.93% | 57.09% | -18.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.85% | 77.08% | -36.23% |
Financials
MOH vs. BNTX - Financials Comparison
This section allows you to compare key financial metrics between Molina Healthcare, Inc. and BioNTech SE. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MOH vs. BNTX - Profitability Comparison
MOH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Molina Healthcare, Inc. reported a gross profit of 0.00 and revenue of 11.38B. Therefore, the gross margin over that period was 0.0%.
BNTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, BioNTech SE reported a gross profit of 568.72M and revenue of 898.89M. Therefore, the gross margin over that period was 63.3%.
MOH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Molina Healthcare, Inc. reported an operating income of -162.00M and revenue of 11.38B, resulting in an operating margin of -1.4%.
BNTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, BioNTech SE reported an operating income of -230.62M and revenue of 898.89M, resulting in an operating margin of -25.7%.
MOH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Molina Healthcare, Inc. reported a net income of -160.00M and revenue of 11.38B, resulting in a net margin of -1.4%.
BNTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, BioNTech SE reported a net income of -302.14M and revenue of 898.89M, resulting in a net margin of -33.6%.